FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/05/2024
Voltar para busca
Dado oficial do USPTO
SORTAC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
21/05/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
22/06/2022
Data de registro
30/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/01/2024
Última transação
30/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DK
Examinador
LATTUCA, FRANK
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
D. A. (pessoa física)
Representantes
JENNIFER A. VAN KIRK LEWIS ROCA ROTHGERBER CHRISTIE LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Biochemical preparations for medical use for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; chemical preparations for medical purposes neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; biological preparations for medical purposes for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; chemical reagents for medical use for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; medical preparations in the form of tabletscapsulessolutionspowders for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; protein synthesis inhibitors being chemical substances and compounds for medical use for the treatment of neurological diseasesinflammatory diseasesmetabolic diseasescancercardiovascular and vascular diseasesgenetic diseaseskidney diseasesprotein aggregation disordersautoimmune diseases; diagnostic preparations and materials namely medical strips
Classe 10
Medical apparatus and instrumentsnamely inhalerspumpsdispensers; Medical instrumentsnamely inhalerspumpsdispensers; diagnosticexamination and monitoring equipment for medical purposesnamely medical strips; all of the aforementioned goods not relating to the field of vascular and/or cardiovascular diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/05/2024
FIMP
FINAL DISPOSITION PROCESSED
01/05/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
30/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/11/2023
PUBO
PUBLISHED FOR OPPOSITION
14/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
13/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/06/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/06/2023
RFNP
REFUSAL PROCESSED BY IB
26/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2023
RFRR
REFUSAL PROCESSED BY MPU
05/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/04/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
17/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/04/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/04/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/04/2023
CNRT
NON-FINAL ACTION WRITTEN
07/04/2023
DOCK
ASSIGNED TO EXAMINER
04/04/2023
MAFR
APPLICATION FILING RECEIPT MAILED
23/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/09/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SORTAC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.